FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to novel polymer compounds, specifically to copolymers of poly-1,4-ethylene piperazine di-N-oxides, which can be used in medical industry in medicinal agents for prevention of development and treatment of various diseases and used as polymer carriers for various proteins and other active substances. Copolymers of poly-1,4-ethylene-piperazine di-N-oxide have general formula I below, in which X=Cl-, Br-, SN3COA-, OH-, k=50–1,000 (from 1 to 99 % of total number of links); l=32–1,000 (from 1 to 90 % of total number of links); m=0–1,000 (from 0 to 50 % of total number of links); n=0–1,000 (from 0 to 50 % of total number of links); p=0–1,000 (from 0 to 50 % of total number of links). According to a first version, a method of producing copolymers of di-N-oxides of poly-1,4-ethylene piperazine of general formula I involves cationic polymerization of 1,4-diazobicyclo[2.2.2]octane at temperature of 150 to 230 °C. Further, the obtained poly-1,4-ethylene-piperazine is oxidized with an aqueous solution of hydrogen peroxide. In compliance with second version obtaining carboxyl-containing derivatives of copolymers of di-N-oxides of poly-1,4-ethylene-piperazine of general formula I, in which p>0. Method of producing carboxyl-containing copolymer derivatives involves alkylation of poly-1,4-ethylene piperazine in aqueous solution with any haloacetic acid, in aqueous solution of acetic acid or in anhydrous acetic acid. Obtained copolymer of 1,4-ethylene piperazine and N-carboxymethyl-1,4-ethylene-piperazine are oxidized with an aqueous solution of hydrogen peroxide.
EFFECT: invention enables to obtain non-toxic copolymers, having antiradical activity and properties protect proteins in chemical stress conditions.
6 cl, 2 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING CONJUGATE OF HYALURONIDASE WITH DERIVATIVES OF POLYETHYLENE PIPERAZINE AND APPLICATION OF PRODUCED CONJUGATE | 2015 |
|
RU2616528C1 |
CONJUGATE OF GLYCOPROTEIN, POSSESSING ERYTHROPOIETIN ACTIVITY, WITH POLY-1,4-ETHYLENEPIPERAZINE N-OXIDE DERIVATIVES (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CONJUGATE OBTAINING | 2013 |
|
RU2556378C2 |
METHOD FOR SIMULTANEOUS DETERMINATION OF DEGREES OF OXIDATION AND ALKYLATION OF AZOXIMER BROMIDE - ACTIVE SUBSTANCE OF POLYOXIDONIUM - BY METHOD C NMR SPECTROSCOPY | 2019 |
|
RU2713805C1 |
CELLULOSE-BASED SULPHATED POLYSACCHARIDE WITH GRAFTED TERPENOPHENOL, METHOD FOR PRODUCTION THEREOF AND AGENT HAVING ANTIRADICAL, ANTIOXIDANT AND MEMBRANE-PROTECTIVE ACTIVITY | 2021 |
|
RU2767207C1 |
VACCINE AGAINST INFECTIONS INDUCED BY OPPORTUNISTIC PATHOGENS | 2001 |
|
RU2204412C2 |
METHOD OF PREPARING POLY-1,4-ETHYLENEPIPERAZINE AND ITS DERIVATIVES | 2000 |
|
RU2185388C2 |
VACCINE AGAINST INFLUENZA VIRUS AND METHOD OF ITS PREPARING | 2000 |
|
RU2164148C1 |
PREPARATION FOR TREATMENT OF CONNECTIVE TISSUE PATHOLOGICAL STATE | 1997 |
|
RU2112542C1 |
GOSSYPOL POLYMER DERIVATIVES, METHODS FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2577539C2 |
COPOLYMERS OF HETERO-CHAIN ALIPHATIC POLY-N-OXIDES, BASED ON THEM VACCINATING AND MEDICINAL PREPARATIONS | 2010 |
|
RU2428991C9 |
Authors
Dates
2020-11-26—Published
2018-06-27—Filed